Companion Animal Blood Glucose Monitoring Market Size, Share, Growth, and Industry Analysis, By Type (Blood Glucose Strips, Glucose Monitors, Urine Glucose Strips), By Application (Veterinary Reference Laboratories, Veterinary Hospitals and Clinics, Point-of-care/In-house Testing, Research Institutes and Universities), Regional Insights and Forecast to 2035
Companion Animal Blood Glucose Monitoring Market Overview
Global Companion Animal Blood Glucose Monitoring Market size is expected to grow from USD 260.91 Million in 2026 to USD 699.79 Million by 2035, registering a steady CAGR of 11.59%.
The Companion Animal Blood Glucose Monitoring Market focuses on diagnostic devices and technologies used for measuring blood glucose levels in pets, especially dogs and cats affected by diabetes and metabolic disorders. The market includes glucose monitors, blood glucose strips, urine glucose strips, and point-of-care testing solutions used by veterinarians and pet owners. Companion animal diabetes cases have increased due to factors such as longer pet lifespans, improved veterinary healthcare access, obesity-related conditions, and better disease detection. Diabetes mellitus is one of the most commonly monitored metabolic disorders in dogs and cats, requiring continuous glucose assessment for effective treatment management. Modern monitoring systems provide faster testing, improved accuracy, and convenient home-based glucose tracking. Advances in biosensor technology, wireless connectivity, and digital veterinary platforms are supporting the adoption of companion animal blood glucose monitoring solutions across veterinary clinics, laboratories, and households.
The companion animal healthcare sector has experienced significant transformation as pet owners increasingly prioritize preventive healthcare and chronic disease management. Dogs and cats represent the largest user base for blood glucose monitoring products because diabetes management requires repeated glucose evaluation. Veterinary professionals use glucose monitoring devices to determine insulin dosage, evaluate treatment response, and monitor health conditions associated with diabetes. Portable glucose meters have improved accessibility by allowing testing outside traditional veterinary environments. The development of veterinary-specific monitoring products has helped overcome challenges associated with human glucose meters, including differences in blood characteristics between humans and animals. Growing awareness about pet wellness, increasing availability of veterinary diagnostic technologies, and rising demand for personalized animal care are strengthening the Companion Animal Blood Glucose Monitoring Market.
Key Findings
- Key Market Driver: Increasing pet healthcare awareness is a major growth factor, with approximately 70% of pet owners considering preventive veterinary care important for improving animal health outcomes and supporting early detection of chronic diseases.
- Major Market Restraint: High equipment costs remain a challenge, with approximately 35% of small veterinary practices reporting limitations in adopting advanced diagnostic technologies because of investment requirements and maintenance expenses.
- Emerging Trends: Digital veterinary monitoring solutions are gaining attention, with nearly 40% of new diagnostic innovations focusing on connected devices, mobile health platforms, and automated data tracking for improved companion animal healthcare.
- Regional Leadership: North America maintains a strong position, supported by approximately 45% of advanced veterinary diagnostic adoption due to developed animal healthcare infrastructure, high pet ownership rates, and increased demand for specialized veterinary services.
- Competitive Landscape: The market includes established veterinary healthcare companies and diagnostic manufacturers, with approximately 50% of product innovation focused on improving accuracy, portability, connectivity, and ease of glucose monitoring.
- Market Segmentation: Glucose monitors and blood glucose strips represent major product categories, with approximately 60% of veterinary testing procedures relying on these solutions because they provide direct and rapid glucose measurements.
- Recent Development: Recent product advancements have focused on digital connectivity, with approximately 30% of newly introduced veterinary monitoring technologies incorporating smart features for data recording, remote tracking, and improved clinical management.
Latest Trends
The Companion Animal Blood Glucose Monitoring Market is witnessing increased adoption of advanced veterinary diagnostic technologies designed to improve diabetes management in companion animals. One major trend is the development of portable glucose monitoring systems that allow veterinarians and pet owners to perform glucose testing conveniently. Traditional laboratory-based testing is gradually being supplemented by handheld monitoring devices that provide faster results and support regular glucose evaluation. Continuous glucose monitoring technology is emerging as an important innovation area within veterinary medicine. These systems use sensor-based technologies to collect glucose information over extended periods, helping veterinarians understand glucose fluctuations and improve insulin management. The increasing availability of wearable monitoring devices is improving chronic disease management for diabetic pets. Another important trend is the integration of digital platforms with veterinary diagnostics. Cloud-based record systems and mobile applications are being introduced to store glucose readings, track treatment progress, and improve communication between veterinarians and pet owners. These technologies support personalized healthcare approaches by allowing better evaluation of individual animal conditions.
How is technological advancement driving the Companion Animal Blood Glucose Monitoring Market?
Technological advancements are driving the Companion Animal Blood Glucose Monitoring Market through improved biosensors, portable glucose meters, continuous glucose monitoring systems, and digital veterinary platforms. Modern devices provide faster results, enhanced accuracy, wireless connectivity, and real-time data tracking. Bluetooth-enabled monitors and mobile applications help veterinarians and pet owners manage diabetes more effectively. These innovations are improving personalized pet healthcare, reducing monitoring challenges, and increasing adoption of advanced glucose testing solutions across veterinary clinics and households.
Market Dynamics
The Companion Animal Blood Glucose Monitoring Market is expanding due to the increasing prevalence of diabetes mellitus in companion animals, growing awareness of preventive veterinary healthcare, and continuous advancements in diagnostic technologies. Blood glucose monitoring has become a routine component of diabetes management in dogs and cats, allowing veterinarians to determine insulin dosage, evaluate treatment response, and prevent complications such as hypoglycemia and diabetic ketoacidosis. The market benefits from improvements in portable glucose meters, veterinary-specific test strips, biosensor technologies, and digital health platforms that simplify routine monitoring.
DRIVER
Increasing prevalence of diabetes in companion animals and expanding preventive veterinary healthcare
Diabetes mellitus has become one of the most frequently diagnosed endocrine disorders among companion animals, particularly senior dogs and middle-aged to older cats. Veterinary studies indicate that approximately 1% of the canine population and nearly 1% of the feline population develop diabetes during their lifetime, with obesity significantly increasing disease risk. More than 60% of diabetic cats are classified as overweight at diagnosis, making routine glucose monitoring essential for disease management. Blood glucose monitoring enables veterinarians to evaluate insulin effectiveness, minimize glucose fluctuations, and improve treatment outcomes. Growing pet ownership further supports market expansion. Globally, companion animal ownership continues to increase, while veterinary visitation rates have improved because owners increasingly seek preventive care rather than treatment only after disease progression. Veterinary associations recommend routine wellness examinations at least 1 time annually for healthy adult pets and 2 times annually for senior animals, increasing opportunities for diabetes screening and glucose testing. Portable blood glucose meters capable of producing results within 10 seconds have improved workflow efficiency in veterinary clinics and emergency hospitals.
RESTRAINT
High cost of veterinary-specific monitoring systems and limited awareness in developing regions
Despite technological progress, the cost of veterinary-specific glucose monitoring equipment remains a significant restraint for smaller veterinary clinics and individual pet owners. Veterinary glucose meters require proprietary blood glucose strips, calibration materials, and quality-control solutions, increasing long-term operating costs. Diabetes management also involves recurring purchases of test strips, lancets, insulin, syringes, and veterinary consultations, making continuous monitoring relatively expensive for some households. Another important limitation is the availability of trained veterinary professionals capable of interpreting glucose curves and adjusting insulin therapy appropriately. In several developing countries, companion animal healthcare infrastructure remains concentrated in major urban centers, limiting access for rural populations. Many pet owners still rely on clinical symptoms rather than routine glucose testing, delaying diagnosis until disease progression occurs. Species-specific physiological differences also create technical challenges. Human glucose meters may produce measurement variations when used in dogs or cats because red blood cell distribution and plasma glucose characteristics differ between species. Consequently, veterinary professionals often recommend animal-calibrated devices, which are generally more expensive than conventional human monitoring systems.
OPPORTUNITY
Expansion of digital veterinary healthcare and continuous glucose monitoring technologies
Digital transformation is creating substantial opportunities within the Companion Animal Blood Glucose Monitoring Market. Connected glucose monitoring systems allow automatic transfer of glucose readings to cloud-based veterinary software, enabling continuous patient monitoring and long-term treatment optimization. Bluetooth-enabled glucose meters and smartphone applications simplify data recording while reducing manual documentation errors. Continuous glucose monitoring (CGM) represents another promising opportunity. Unlike conventional spot testing, CGM sensors provide glucose measurements every few minutes over several days, allowing veterinarians to identify hidden glucose fluctuations that cannot be detected through single blood samples. This technology improves insulin dose adjustment and reduces stress associated with repeated blood collection. Artificial intelligence is also creating opportunities by analyzing glucose patterns and generating predictive alerts for abnormal trends. Machine learning algorithms can identify recurring glucose variability, helping veterinarians personalize treatment plans more effectively. Telemedicine integration further expands opportunities by allowing veterinarians to review glucose data remotely and provide follow-up consultations without requiring frequent clinic visits.
CHALLENGE
Maintaining analytical accuracy across different animal species while improving affordability
Maintaining consistent analytical accuracy remains one of the most significant challenges in the Companion Animal Blood Glucose Monitoring Market. Dogs and cats exhibit physiological characteristics that differ substantially from humans, requiring veterinary-specific calibration algorithms to produce reliable glucose measurements. Differences in hematocrit values, plasma composition, and species-specific blood chemistry can influence measurement accuracy if inappropriate monitoring systems are used. Another challenge involves ensuring proper user training. Accurate glucose measurement depends on correct blood sample collection, strip handling, device calibration, and timing of insulin administration. Improper sampling techniques can produce inaccurate readings that affect treatment decisions. Veterinary clinics therefore invest considerable time educating pet owners regarding home monitoring procedures. Regulatory compliance presents another obstacle for manufacturers. Veterinary diagnostic devices must undergo rigorous analytical validation, quality assurance testing, and manufacturing controls before commercialization. Product development cycles may extend for several years as companies optimize sensor performance, software integration, and device reliability.
Why is demand increasing for the Companion Animal Blood Glucose Monitoring Industry?
Demand for the Companion Animal Blood Glucose Monitoring Industry is increasing due to rising pet ownership, growing awareness of preventive veterinary care, and higher prevalence of diabetes among dogs and cats. Longer pet lifespans, obesity-related health issues, and improved veterinary diagnostics are encouraging regular glucose monitoring. Pet owners are increasingly investing in chronic disease management solutions to improve animal health outcomes. The need for accurate insulin management and early disease detection is further supporting market expansion.
Segmentation Analysis
The Companion Animal Blood Glucose Monitoring Market is segmented based on product type and application. Product segmentation includes blood glucose strips, glucose monitors, and urine glucose strips, each serving different diagnostic requirements. Glucose monitors provide direct measurement capabilities, while blood glucose strips support routine testing procedures. Application segmentation includes veterinary reference laboratories, veterinary hospitals and clinics, point-of-care or in-house testing, and research institutes and universities. Veterinary hospitals and point-of-care testing facilities represent important application areas because glucose monitoring is frequently required for diabetes diagnosis and treatment management. Increasing adoption of advanced veterinary diagnostic technologies is influencing demand across all segments.
By Type
Blood Glucose Strips: Blood glucose strips represent a critical component of the Companion Animal Blood Glucose Monitoring Market because they provide the testing medium required for glucose measurement devices. These strips are designed to analyze blood samples collected from companion animals and provide rapid glucose readings. Veterinary professionals commonly use blood glucose strips during diabetes diagnosis, insulin adjustment, and routine monitoring procedures. The demand for glucose strips is supported by the need for repeated testing because diabetic animals require regular monitoring throughout treatment. Improvements in strip design have focused on reducing sample requirements, improving accuracy, and increasing compatibility with portable glucose meters.
Glucose Monitors: Glucose monitors are among the most important products in the Companion Animal Blood Glucose Monitoring Market because they provide direct measurement and digital display of blood glucose levels. These devices are used by veterinary professionals and pet owners to monitor diabetes progression and evaluate treatment effectiveness. Modern glucose monitors include portable designs, improved sensor technology, and enhanced measurement accuracy. Handheld monitoring devices allow faster testing in veterinary clinics and home environments. The adoption of glucose monitors is increasing because they reduce the time required for obtaining diagnostic results compared with traditional laboratory methods.
Urine Glucose Strips: Urine glucose strips represent an additional diagnostic approach used in companion animal healthcare for detecting glucose presence in urine samples. These strips are generally used as supportive diagnostic tools for identifying abnormal glucose levels and monitoring diabetic conditions. Although blood glucose monitoring provides more precise information for insulin management, urine testing remains useful because it offers a simple and affordable testing method. Veterinary professionals may use urine glucose strips during initial assessments or when blood sampling is difficult. The segment continues to support the broader companion animal diagnostic ecosystem by providing accessible testing options.
By Application
Veterinary Reference Laboratories: Veterinary reference laboratories play an important role in the Companion Animal Blood Glucose Monitoring Market because they provide specialized diagnostic services for complex animal health conditions. These laboratories use advanced testing technologies to confirm diabetes diagnosis, evaluate metabolic disorders, and support veterinary decision-making. Reference laboratories generally handle larger testing volumes and require accurate diagnostic equipment capable of delivering reliable results. Blood glucose analysis is often combined with additional laboratory evaluations to understand overall animal health conditions. Increasing demand for specialized veterinary diagnostics is encouraging laboratories to adopt improved monitoring technologies.
Veterinary Hospitals and Clinics: Veterinary hospitals and clinics represent one of the largest application areas for companion animal blood glucose monitoring systems. These facilities use glucose monitors and testing strips for diabetes diagnosis, emergency care, routine examinations, and long-term disease management. Veterinary clinics require reliable monitoring equipment because glucose levels directly influence insulin dosage decisions for diabetic pets. Portable glucose meters are increasingly used because they allow quick testing during consultations and treatment procedures. The rising number of veterinary facilities adopting advanced diagnostic tools is supporting market development. Clinics are also educating pet owners about home monitoring practices, increasing demand for consumer-friendly glucose testing devices.
Point-of-care/In-house Testing: Point-of-care and in-house testing applications are expanding because they provide immediate glucose measurement results without requiring external laboratory processing. Veterinary professionals use these systems during clinical visits, emergency situations, and routine monitoring procedures. The ability to obtain rapid results helps veterinarians make faster treatment decisions, particularly for diabetic animals requiring insulin adjustments. Pet owners are also showing greater interest in home-based glucose monitoring because it reduces frequent clinic visits and supports continuous disease management. Portable testing devices are becoming more common due to their convenience and simplified operation.
Research Institutes and Universities: Research institutes and universities contribute to the Companion Animal Blood Glucose Monitoring Market by conducting studies related to animal diabetes, metabolic disorders, and veterinary diagnostic technologies. These institutions evaluate new monitoring methods, sensor technologies, and treatment approaches. Research activities help improve understanding of glucose regulation in companion animals and support development of advanced diagnostic products. Veterinary education programs also use glucose monitoring equipment to train future professionals in animal healthcare management. Collaboration between researchers and diagnostic manufacturers encourages innovation in veterinary medicine.
Which segment is growing faster in the Companion Animal Blood Glucose Monitoring Market?
The glucose monitors segment is growing faster in the Companion Animal Blood Glucose Monitoring Market due to increasing demand for portable and accurate testing devices. These monitors enable quick blood glucose measurement in veterinary clinics and home environments, supporting effective diabetes management. Advancements in digital connectivity, sensor technology, and user-friendly designs are accelerating adoption. Point-of-care testing applications are also expanding as veterinarians and pet owners seek faster diagnostic results and convenient monitoring solutions.
Regional Outlook
The Companion Animal Blood Glucose Monitoring Market shows strong development across North America, Europe, Asia-Pacific, and the Middle East & Africa due to differences in veterinary infrastructure, pet ownership patterns, and healthcare adoption. North America maintains a leading position because of advanced veterinary services and higher acceptance of companion animal diagnostics. Europe demonstrates steady demand supported by animal welfare awareness and developed healthcare systems. Asia-Pacific is expanding due to increasing pet ownership, urbanization, and improving veterinary facilities. Middle East & Africa represent developing markets where awareness regarding companion animal healthcare is gradually increasing.
North America
North America represents a significant region in the Companion Animal Blood Glucose Monitoring Market due to advanced veterinary infrastructure, high pet ownership, and strong demand for specialized animal healthcare services. The United States and Canada have developed veterinary networks that widely use diagnostic technologies for chronic disease management. Companion animal diabetes management has become an important healthcare area because pets are living longer and require continuous monitoring for age-related conditions. Veterinary hospitals, specialty clinics, and emergency care centers increasingly use glucose monitoring systems to support treatment decisions. The region benefits from strong awareness among pet owners regarding preventive healthcare. Many owners seek early diagnosis and regular monitoring for conditions such as diabetes, obesity-related disorders, and metabolic abnormalities. The presence of veterinary specialists and advanced diagnostic facilities supports adoption of blood glucose monitoring technologies. Technological innovation is another important factor influencing regional growth. Manufacturers are developing portable glucose monitors, connected devices, and sensor-based systems designed specifically for veterinary applications. Digital platforms that allow glucose data tracking are gaining attention among veterinary professionals.
Europe
Europe represents an important region in the Companion Animal Blood Glucose Monitoring Market due to increasing emphasis on animal welfare, advanced veterinary healthcare systems, and growing adoption of diagnostic technologies. Countries across Western Europe have developed veterinary networks where blood glucose monitoring devices are commonly used for managing chronic conditions in companion animals. Dogs and cats remain the primary focus because diabetes requires regular glucose evaluation and long-term treatment management. The region benefits from strong awareness regarding preventive veterinary care. Pet owners are increasingly seeking early diagnosis and improved treatment options for chronic diseases. Veterinary clinics are adopting portable glucose monitors and blood testing solutions to provide faster clinical assessments. The growing preference for personalized veterinary medicine is encouraging the use of diagnostic technologies that support individualized treatment plans. European veterinary professionals are also focusing on improving disease management through accurate monitoring methods. Glucose monitoring systems help veterinarians evaluate insulin response, identify glucose fluctuations, and improve treatment adjustments.
Asia-Pacific
Asia-Pacific is emerging as a developing region in the Companion Animal Blood Glucose Monitoring Market because of increasing pet ownership, urbanization, and improving access to veterinary healthcare services. Countries such as China, Japan, South Korea, India, and Australia are experiencing greater demand for companion animal healthcare products as pets become increasingly considered family members. Urban lifestyles and changing consumer attitudes toward pet wellness are supporting the adoption of advanced veterinary diagnostics. Pet owners in major cities are showing greater interest in preventive healthcare, routine examinations, and chronic disease management. This trend is increasing the need for glucose monitoring solutions for diabetic dogs and cats. Veterinary infrastructure in Asia-Pacific is improving through the expansion of animal hospitals, specialty clinics, and diagnostic centers. Larger cities are witnessing increased adoption of portable glucose monitors because veterinary professionals require fast and reliable testing methods. Point-of-care testing is becoming more important because it reduces dependence on external laboratory services. Japan and Australia represent mature veterinary markets within the region due to developed healthcare systems and strong animal welfare awareness.
Middle East & Africa
The Middle East & Africa region represents an emerging market for companion animal blood glucose monitoring solutions as awareness regarding veterinary healthcare continues to increase. Companion animal ownership is growing in urban areas, leading to higher demand for professional veterinary services and diagnostic technologies. Veterinary clinics in developed areas of the Middle East are increasingly adopting modern diagnostic equipment to provide advanced healthcare services for pets. Countries with stronger healthcare infrastructure are showing greater acceptance of glucose monitoring devices for diabetes management and routine animal health evaluation. In Africa, market development is influenced by improving veterinary access, increasing awareness about animal diseases, and gradual expansion of veterinary facilities. Companion animal healthcare is still developing in many areas, but urban populations are increasingly seeking better medical care for pets. The region faces challenges related to limited veterinary infrastructure, lower availability of specialized equipment, and differences in healthcare accessibility. These factors can affect adoption of advanced glucose monitoring technologies. However, increasing investments in veterinary education and healthcare modernization are creating opportunities for future market expansion.
Which region dominates the Companion Animal Blood Glucose Monitoring Industry?
North America dominates the Companion Animal Blood Glucose Monitoring Industry due to advanced veterinary healthcare infrastructure, high pet ownership rates, and strong adoption of diagnostic technologies. The region benefits from increasing demand for companion animal wellness services, specialized veterinary clinics, and innovative glucose monitoring solutions. The United States and Canada have well-established veterinary networks supporting diabetes management in pets. Rising investment in digital veterinary healthcare and preventive animal care further strengthens regional market leadership.
List of Top Companion Animal Blood Glucose Monitoring Market Companies
- Zoetis
- ACON Laboratories
- Nova Biomedical
- VivaChek Laboratories, Inc.
- Ultimed
- I-Sens
- Pharma Supply
- Arkray
- Teco Diagnostics
- Biotest Medical Corp
- Woodley Equipment
Top 2 Companies Market Share
- Zoetis: Zoetis is one of the leading animal healthcare companies globally, with a strong presence in veterinary diagnostics, pharmaceuticals, and companion animal health solutions. The company focuses on developing technologies that support disease detection, treatment management, and preventive veterinary care.
- Nova Biomedical: Nova Biomedical is recognized for its diagnostic technology expertise, including glucose measurement solutions used across healthcare applications. The company contributes to veterinary monitoring through diagnostic innovation and development of accurate testing systems.
Investment Analysis and Opportunities
The Companion Animal Blood Glucose Monitoring Market presents investment opportunities due to increasing demand for advanced veterinary diagnostic technologies and rising focus on companion animal healthcare. Investors are showing interest in veterinary technology companies developing portable monitoring devices, digital health platforms, and connected diagnostic solutions. One major opportunity area is the development of continuous glucose monitoring systems designed specifically for animals. These technologies can improve diabetes management by providing more detailed glucose information compared with traditional testing methods. The increasing acceptance of home-based veterinary care is creating opportunities for companies developing simple and reliable monitoring solutions. Investment opportunities are also emerging in software-based veterinary healthcare platforms. Digital systems that integrate glucose data, treatment records, and veterinary communication tools can improve disease management efficiency. Companies combining diagnostic hardware with digital solutions may gain competitive advantages in the evolving veterinary technology sector. Emerging markets provide additional opportunities due to increasing pet ownership and improving veterinary infrastructure.
New Product Development
Product innovation remains one of the strongest competitive factors in the Companion Animal Blood Glucose Monitoring Market. Manufacturers are concentrating on improving analytical accuracy, reducing blood sample volume, shortening test time, and enhancing ease of use for both veterinarians and pet owners. New-generation veterinary glucose monitors are designed with species-specific calibration for dogs and cats, helping improve measurement consistency compared with conventional human glucose meters. Many recently introduced devices include memory storage capable of recording more than 500 test results, allowing veterinarians to evaluate long-term glucose patterns during diabetes management. Wireless connectivity has become a key development area. Several manufacturers are integrating Bluetooth communication with mobile applications, enabling automatic transfer of glucose readings to smartphones and veterinary software platforms. Digital record management reduces manual documentation and supports more accurate treatment adjustments. Some systems also provide reminder functions for insulin administration and scheduled glucose testing, improving compliance among pet owners. Continuous glucose monitoring (CGM) technology is another important innovation.
Five Recent Developments (2023–2025)
- 2023: Zoetis expanded its digital veterinary ecosystem by strengthening integration between diagnostic data management platforms and companion animal clinical workflows, improving access to patient monitoring information for veterinary professionals.
- 2023: Arkray continued development of veterinary glucose monitoring technologies by enhancing biosensor performance and improving measurement stability for companion animal applications.
- 2024: Nova Biomedical introduced improvements to point-of-care glucose testing technology emphasizing faster processing, simplified operation, and enhanced analytical performance suitable for veterinary diagnostic environments.
- 2024: I-Sens increased research activities focused on advanced biosensor technology and portable diagnostic solutions supporting improved glucose monitoring efficiency across animal healthcare applications.
- 2025: Several veterinary diagnostic manufacturers accelerated development of digital health integration by expanding compatibility between glucose monitoring devices, cloud-based veterinary software, and mobile applications to improve long-term diabetes management for companion animals.
Report Coverage
The Companion Animal Blood Glucose Monitoring Market report provides comprehensive analysis of the global industry, covering product categories, application sectors, regional developments, competitive landscape, technological innovations, and emerging industry trends. The report evaluates blood glucose strips, glucose monitors, and urine glucose strips while assessing their roles in companion animal diabetes diagnosis and long-term disease management. The report examines major application areas including veterinary reference laboratories, veterinary hospitals and clinics, point-of-care or in-house testing, and research institutes and universities. Each application segment is evaluated according to diagnostic requirements, technology adoption, and clinical significance within veterinary healthcare. Regional analysis includes North America, Europe, Asia-Pacific, and the Middle East & Africa. The report reviews differences in veterinary infrastructure, pet ownership trends, healthcare accessibility, and adoption of advanced diagnostic technologies. Regional comparisons highlight how economic development, veterinary education, and animal welfare awareness influence demand for glucose monitoring products. Competitive analysis covers leading manufacturers including Zoetis, Nova Biomedical, Arkray, ACON Laboratories, VivaChek Laboratories, Ultimed, I-Sens, Pharma Supply, Teco Diagnostics, Biotest Medical Corp, and Woodley Equipment.
Companion Animal Blood Glucose Monitoring Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 260.91 Million in 2026 |
|
|
Market Size Value By |
USD 699.79 Million by 2035 |
|
|
Growth Rate |
CAGR of 11.59% from 2026-2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Companion Animal Blood Glucose Monitoring Market is expected to reach USD 699.79 Million by 2035.
The Companion Animal Blood Glucose Monitoring Market is expected to exhibit a CAGR of 11.59% by 2035.
Zoetis, ACON Laboratories, Nova Biomedical, VivaChek Laboratories, Inc., Ultimed, I-Sens, Pharma Supply, Arkray, Teco Diagnostics, Biotest Medical Corp, Woodley Equipment
In 2026, the Companion Animal Blood Glucose Monitoring Market value will reach at USD 260.91 Million.